Evaluation of Miricorilant on Liver Fat in Patients With MASLD

Clinical trial NCT06947304 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06947304
Sponsor: Corcept Therapeutics
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Nonalcoholic Steatohepatitis (NASH)Metabolic Dysfunction-Associated Steatohepatitis (MASH)Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)Non-alcoholic Fatty Liver Disease (NAFLD)

Start date: 2025-08-22
Primary completion: 2026-08-01
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.